SANDRA HEADRICK: Open Payments
NPI 1891786414 · ROLLA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 26 payments from 12 companies in 2025. Trend: 2023 $334 · 2024 $600 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $177 |
| Inspire Medical Systems, Inc. | 1 | $92 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| ABBVIE INC. | 3 | $49 |
| Novo Nordisk Inc | 2 | $43 |
| Lilly USA, LLC | 2 | $37 |
| Phadia US Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: CAPLYTA, INSPIRE, Wegovy, FARXIGA, MOUNJARO, VRAYLAR, ImmunoCAP, Auvelity.
Industry payments across MO — which companies pay providers there.
